Cargando…
Association of Toxicity of Sorafenib and Sunitinib for Human Keratinocytes with Inhibition of Signal Transduction and Activator of Transcription 3 (STAT3)
Hand–foot skin reaction is a most common multi-kinase inhibitor-related adverse event. This study aimed to examine whether the toxicity of sorafenib and sunitinib for human keratinocytes was associated with inhibiting signal transduction and activator of transcription 3 (STAT3). We studied whether S...
Autores principales: | Yamamoto, Kazuhiro, Mizumoto, Atsushi, Nishimura, Kohji, Uda, Atsushi, Mukai, Akira, Yamashita, Kazuhiko, Kume, Manabu, Makimoto, Hiroo, Bito, Toshinori, Nishigori, Chikako, Nakagawa, Tsutomu, Hirano, Takeshi, Hirai, Midori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094497/ https://www.ncbi.nlm.nih.gov/pubmed/25013907 http://dx.doi.org/10.1371/journal.pone.0102110 |
Ejemplares similares
-
Everolimus-induced human keratinocytes toxicity is mediated by STAT3 inhibition
por: Yamamoto, Kazuhiro, et al.
Publicado: (2013) -
Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt Signaling Suppresses Cell Proliferation and Survival through Regulation of Stat3 Activation in Human Cutaneous Squamous Cell Carcinoma
por: Bito, Toshinori, et al.
Publicado: (2011) -
Sorafenib and sunitinib: A dermatologist's perspective
por: Pragasam, Vijendran, et al.
Publicado: (2014) -
Efficacy of sequential therapies with sorafenib-sunitinib versus sunitinib-sorafenib in metastatic renal cell carcinoma: A systematic review and meta-analysis
por: Wen, Tingyu, et al.
Publicado: (2017) -
Sunitinib and Sorafenib Modulating Antitumor Immunity in Hepatocellular Cancer
por: Liu, Dai, et al.
Publicado: (2018)